openPR Logo
Press release

Blood Cancer Drugs Market Key Players, Applications, Product and Production Information analysis and forecast to 2023

04-05-2018 02:38 PM CET | Health & Medicine

Press release from: Infinium Global Research

Blood Cancer Drugs Market Key Players, Applications, Product

The value of the global blood cancer drugs market was USD X.X billion during 2015. The global blood cancer drugs market is projected to reach USD X.XX billion by 2023, growing with a CAGR between 10.5% to 11.5% from 2017 to 2023. Due to the improved healthcare systems across the world, the rate of diagnosis of blood cancers has improved significantly and it drives the demand for the blood cancer drugs. The presence of large geriatric population in the world is expected to provide more demand for the blood cancer drugs as blood cancers except acute lymphocytic leukaemia and Hodgkin’s lymphoma affect aged people to a large extent. Chemotherapeutic drugs segment is anticipated to garner more demand and drive the growth of the global blood cancer drugs market due to availability of wide range of various chemotherapeutic drugs for blood cancer. Moreover, owing to their effectiveness, the demand for personalised cancer drugs is expected to increase significantly during the forecast period.

Get Sample Copy of this Report: https://www.infiniumglobalresearch.com/reports/sample_request/20

Increasing number of leukaemia patients is generating more demand for blood cancer drugs. As many of the leukaemia cases are undetected in initial stage, the emphasis is on effective drugs for recovery. The leukaemia segment is expected to drive the growth of the global blood cancer drugs market. Biological drugs for cancer are attaining more demand despite the high cost, due to their effectiveness and minimal side effects in curing or bringing relief to the blood cancer patients. Additionally, biosimilars of respective biological cancer drugs are expected to attain significant demand in regions where the affordability of costly biological drugs is an issue. Similarly, immunotherapy for blood cancer is likely to grow significantly as an alternative for chemotherapy over the forecast period, due to the lesser side effects and improved efficiency. These segments are anticipated to enhance the growth of the global blood cancer drugs market during the forecast period. The expiry of patents on some of the major chemotherapeutic blood cancer drugs in coming years is expected to provide opportunity for generic manufacturers to manufacture low-cost generic versions of those and it is expected to escalate the growth of the global blood cancer drugs market. Huge investments in research and development of blood cancer by major pharmaceutical companies are anticipated to further boost the global blood cancer drugs market during the forecast period.

The higher costs of blood cancer drugs and therapies and the lack of supportive reimbursement policies and insurance coverage for blood cancer therapies in many regions are the major restraints for the global blood cancer drugs market. Biosimilars of biological drugs and generics of chemical drugs for cancer is expected to provide opportunity for pharmaceutical companies to expand in the developing and least developed countries, where the high costs of traditional blood cancer drugs are unaffordable for patients, during the forecast period. Providing cost effective blood cancer drugs to the patients will be a major challenge for the major pharmaceutical companies, due to the high investments required  for  research and development and manufacturing, during the forecast period.

Segments Covered:

The report segments the global blood cancer drugs market by product and region. On the basis of product, the market is segmented as rituaxan/mabthera, gleevac/glivec, revlimid, velcade, tasigna, pomalyst, vidaza, kyprolis, adcetris, and others.

For More Enquiry on This Report: https://www.infiniumglobalresearch.com/reports/enquiry/20

Geographic Coverage and Analysis:

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. North American region is the largest blood cancer drugs market, due to the presence of advanced diagnostic facilities and numerous blood cancer patients in USA. Presence of good healthcare facilities for cancer related treatments and affordability among public owing to the favorable reimbursement and insurance policies drive the growth of the North American blood cancer drugs market.  Moreover, the presence of major Pharmaceutical companies in the region and their huge investments in research and development of blood cancer drugs is yielding new effective blood cancer drugs in the region. The increasing awareness and preference for immunotherapy due to efficiency is expected to drive the North American blood cancer market during the forecast period. Presence of large geriatric population and good healthcare facilities for cancer treatments drive the European blood cancer drugs market. Due high rate of diagnosis of blood cancer at initial stages and awareness about treatments among patients, the demand for the blood cancer drugs is high in Europe and it drives the growth of the market. The expiry of patents of major blood cancer drugs is expected to drive the growth of manufacturing of generic blood cancer drugs in near future.

Moreover, Europe has the policy to promote biologics and biosimilar drugs as an alternative for chemotherapeutic drugs and it is expected to drive the European blood cancer drugs market. The initiatives of major pharmaceutical companies to expand the operations in Presence of huge population, increasing awareness about the blood cancer, investments by governments to improved healthcare facilities for cancer treatments and promotion of alternative therapies such as immunotherapy and biologics are expected to drive the growth of the Asia-Pacific blood cancer market. Low cost generic and biosimilar drugs for blood cancer are expected to generate more demand in the Asia-Pacific blood cancer drugs market during the forecast period.

The report provides profiles of the companies in the global blood cancer drugs market such as, Amgen Inc, AstraZeneca PLC, Astellas Pharma Inc, Bayer AG, Bristol-Myers Squibb Company, Celgene Corporation, Eli Lilly, F.Hoffmann-La Roche Ltd., Johnson & Johnson, Novartis, Pfizer Inc, Takeda Pharmaceutical Company Ltd, AbbVie Inc.

Complete report at: https://www.infiniumglobalresearch.com/healthcare_medical_devices/blood_cancer_drugs_market

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of blood cancer drugs globally as well as regionally. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.  The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of blood cancer drugs. Moreover, the study highlights current market trends and provides forecast from 2016 to 2023. We also have highlighted future trends in the blood cancer drugs market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors of the blood cancer drugs market to understand the present and future trends in this market and formulate their strategies accordingly

About Us

Infinium Global Research and Consulting Solutions is started with a single motto of being business partner of first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.

Contact Us

Infinium Global Research,
Toll Free:
U.S. + Canada: 1-800-638-0796,
Website : https://www.infiniumglobalresearch.com
Email: sales@infiniumglobalresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Blood Cancer Drugs Market Key Players, Applications, Product and Production Information analysis and forecast to 2023 here

News-ID: 1004828 • Views:

More Releases from Infinium Global Research

Global Aircraft Tyre Market Size Worth USD 2478.09 Million By 2030 | CAGR 5.47%: Infinium Global Research
Global Aircraft Tyre Market Size Worth USD 2478.09 Million By 2030 | CAGR 5.47%: …
Infinium Global Research, a prominent market research firm, has released an in-depth report providing a comprehensive analysis of the Global Aircraft Tyre Market. The report dives into segments and sub-segments, highlighting both global trends and regional insights that significantly impact this dynamic industry. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1058 Steady Market Growth The global aircraft tyre market, valued at USD 1634.41 million in 2022, is anticipated to surge to
Global Automotive Interior Leather Market to Hit USD 61.6 Billion, Globally By 2030 at 6.50% CAGR | Infinium Global Research
Global Automotive Interior Leather Market to Hit USD 61.6 Billion, Globally By 2 …
Infinium Global Research, a leading research firm, has published an extensive report providing a detailed analysis of the Global Automotive Interior Leather Market. The report offers comprehensive insights into segments and sub-segments, highlighting both global trends and regional dynamics shaping this thriving industry. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1266 Steady Market Growth The global automotive interior leather market, valued at USD 30.82 billion in 2022, is projected to skyrocket
Global Automatic Car Wash Market Growing at a CAGR of 4.01% to Reach USD 5.82 Billion By 2030 | Infinium Global Research
Global Automatic Car Wash Market Growing at a CAGR of 4.01% to Reach USD 5.82 Bi …
Infinium Global Research, a leading authority in market analysis, has released an extensive report offering a deep dive into the Global Automatic Car Wash Market. The report presents an in-depth analysis of segments and sub-segments, shedding light on both global trends and regional dynamics impacting this burgeoning industry. To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1295 Robust Market Growth The automatic car wash market, valued at USD 4.04 billion
Global Automotive Logistics Market is Anticipated to Reach USD 363.03 Billion at a Robust CAGR of 5.51% Between 2023 to 2030 | Infinium Global Research
Global Automotive Logistics Market is Anticipated to Reach USD 363.03 Billion at …
Infinium Global Research, a leading market research firm, has released an expansive report offering an in-depth analysis of the Global Automotive Logistics Market. The report delves into crucial segments and sub-segments, shedding light on both global and regional dynamics impacting this intricate industry. The comprehensive study reveals the profound impact of drivers, restraints, and macro indicators on the automotive logistics market. Providing a comprehensive outlook, the report highlights evolving trends, forecasts,

All 5 Releases


More Releases for Europe

2019 Strategy Consulting Market Analysis | McKinsey, The Boston Consulting Group …
Strategy Consulting Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends Need for strategic planning in highly competitive environment and to develop business capabilities to meet & exceed the emerging requirements are the major drivers which help in surging
Strategy Consulting Market 2025 | Analysis By Top Key Players: Booz & Co. , Rola …
Global Strategy Consulting Market 2019-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The key players covered in this study McKinsey , The Boston Consulting Group , Bain & Company , Booz & Co. , Roland Berger Europe
Digital Strategy Consulting Market is Thriving Worldwide with Deloitte, McKinsey …
A Digital Strategy is a form of strategic management and a business answer or response to a digital question, often best addressed as part of an overall business strategy. A digital strategy is often characterized by the application of new technologies to existing business activity and focus on the enablement of new digital capabilities to their business. A new report as a Digital Strategy Consulting market that includes a comprehensive analysis
Strategy Consulting Market 2019: By McKinsey, The Boston Consulting Group, Bain …
This report studies the global Strategy Consulting market, analyzes and researches the Strategy Consulting development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like • McKinsey • The Boston Consulting Group • Bain & Company • Booz & Co. • Roland Berger Europe • Oliver Wyman Europe • A.T. Kearney Europe • Deloitte • Accenture Europe Get Sample Report@ https://www.reporthive.com/enquiry.php?id=1247388&req_type=smpl&utm_source=AB Market segment by Type, the product can be split into • Operations Consultants • Business Strategy Consultants • Investment Consultants • Sales and
Strategy Consulting Market Analysis 2018: McKinsey, The Boston Consulting Group, …
Orbis Research Present’s “Global Strategy Consulting Market” magnify the decision making potentiality and helps to create an effective counter strategies to gain competitive advantage. The global Strategy Consulting status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Strategy Consulting development in United States, Europe and China. In 2017, the global Strategy Consulting market size was million US$ and it is expected to reach million
Influenza Vaccination Market Global Forecast 2018-25 Estimated with Top Key Play …
UpMarketResearch published an exclusive report on “Influenza Vaccination market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Influenza Vaccination market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This